Repository logo
 

Current state of high-fidelity multimodal monitoring in traumatic brain injury.

Published version
Peer-reviewed

Change log

Authors

Lindblad, Caroline 
Raj, Rahul 
Zeiler, Frederick A 
Thelin, Eric P 

Abstract

INTRODUCTION: Multimodality monitoring of patients with severe traumatic brain injury (TBI) is primarily performed in neuro-critical care units to prevent secondary harmful brain insults and facilitate patient recovery. Several metrics are commonly monitored using both invasive and non-invasive techniques. The latest Brain Trauma Foundation guidelines from 2016 provide recommendations and thresholds for some of these. Still, high-level evidence for several metrics and thresholds is lacking. METHODS: Regarding invasive brain monitoring, intracranial pressure (ICP) forms the cornerstone, and pressures above 22 mmHg should be avoided. From ICP, cerebral perfusion pressure (CPP) (mean arterial pressure (MAP)-ICP) and pressure reactivity index (PRx) (a correlation between slow waves MAP and ICP as a surrogate for cerebrovascular reactivity) may be derived. In terms of regional monitoring, partial brain tissue oxygen pressure (PbtO2) is commonly used, and phase 3 studies are currently ongoing to determine its added effect to outcome together with ICP monitoring. Cerebral microdialysis (CMD) is another regional invasive modality to measure substances in the brain extracellular fluid. International consortiums have suggested thresholds and management strategies, in spite of lacking high-level evidence. Although invasive monitoring is generally safe, iatrogenic hemorrhages are reported in about 10% of cases, but these probably do not significantly affect long-term outcome. Non-invasive monitoring is relatively recent in the field of TBI care, and research is usually from single-center retrospective experiences. Near-infrared spectrometry (NIRS) measuring regional tissue saturation has been shown to be associated with outcome. Transcranial doppler (TCD) has several tentative utilities in TBI like measuring ICP and detecting vasospasm. Furthermore, serial sampling of biomarkers of brain injury in the blood can be used to detect secondary brain injury development. CONCLUSIONS: In multimodal monitoring, the most important aspect is data interpretation, which requires knowledge of each metric's strengths and limitations. Combinations of several modalities might make it possible to discern specific pathologic states suitable for treatment. However, the cost-benefit should be considered as the incremental benefit of adding several metrics has a low level of evidence, thus warranting additional research.

Description

Funder: Stockholms Läns Landsting; doi: http://dx.doi.org/10.13039/501100004348


Funder: Familjen Erling-Perssons Stiftelse; doi: http://dx.doi.org/10.13039/100007436


Funder: Strategic Research Area Neuroscience


Funder: Karolinska Institute

Keywords

Biomarkers, Intracranial pressure, Multimodal monitoring, Neuro-critical care, Traumatic brain injury, Humans, Retrospective Studies, Intracranial Pressure, Brain Injuries, Traumatic, Cerebrovascular Circulation, Brain Injuries, Monitoring, Physiologic

Journal Title

Acta Neurochir (Wien)

Conference Name

Journal ISSN

0001-6268
0942-0940

Volume Title

164

Publisher

Springer Science and Business Media LLC
Sponsorship
Natural Sciences and Engineering Research Council of Canada (NSERC) (DGECR-2022-00260, RGPIN-2022-03621)
Canadian Institutes of Health Research (CIHR) (472286)
the Canada Foundation for Innovation (CFI) (38583)
Research Manitoba (3906)